Genesis HealthCare (GEN) Tops Q1 EPS by 4c; offers guidance

Genesis HealthCare (NASDAQ: GEN) reported Q1 EPS of $0.64, $0.04 better than the analyst estimate of $0.60. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.19 billion.

GUIDANCE:

Genesis HealthCare sees Q2 2026 EPS of $0.60-$0.62, versus the consensus of $0.61. Genesis HealthCare sees Q2 2026 revenue of $1.18-1.21 billion, versus the consensus of $1.169 billion.

Genesis HealthCare sees FY2026 EPS of $2.49-$2.56, versus the consensus of $2.50. Genesis HealthCare sees FY2026 revenue of $4.8-4.9 billion, versus the consensus of $4.758 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
• UBS Reiterates Neutral Rating on Brenntag AG (BNR:GR) (BNTGY)
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings